Drug intelligence / Profile preview

Sijun Wupi Decoction

Development stage: Preclinical
Lead developer: Subject declaration
Administration: Oral

Overview

Sijun Wupi Decoction is a traditional Chinese medicine (TCM) decoction currently under investigation for its clinical efficacy in treating refractory ascites due to liver cirrhosis. It is often studied in combination with conventional Western medicine treatments. In the context of Traditional Chinese Medicine, its therapeutic action is understood to be based on the spleen governing transportation and chemistry.

Beyond the preview

Go deeper on Sijun Wupi Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sijun Wupi Decoction.

Explore the full profile